Detalhe da pesquisa
1.
Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases.
Kidney Int
; 102(2): 405-420, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643372
2.
Real-world study: Escalating targeted lipid-lowering treatment with PCSK9-inhibitors and lipoprotein apheresis.
J Clin Apher
; 34(4): 423-433, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30817043
3.
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity.
Pediatr Nephrol
; 33(7): 1199-1208, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29502162
4.
Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis.
Am J Cardiol
; 136: 38-48, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32946862
5.
Case report-Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia.
J Clin Lipidol
; 12(4): 868-871, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29866529